Pan-cancer proteogenomic landscape of whole-genome doubling reveals putative therapeutic targets in various cancer types
1. Department of Integrated Biomedical and Life Science, Korea University, Seoul, Republic of Korea
2. L-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, Republic of Korea
3. Department of Applied Chemistry, Institute of Natural Science, Kyung Hee University, Yongin, Republic of Korea
4. Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
5. Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, Republic of Korea
6. Department of Biology, Kyung Hee University, Seoul, Republic of Korea
7. Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea
8. Department of New Biology, DGIST, Daegu, Republic of Korea
9. New Biology Research Center, DGIST, Daegu, Republic of Korea
10. Center for Cell Fate Reprogramming and Control, DGIST, Daegu, Republic of Korea
11. SG Medical, Inc., Seoul, Republic of Korea
12. Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA
13. Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California, USA
14. School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, Republic of Korea
kimkp@khu.ac.kr
joonan30@korea.ac.kr
Show less
PDF
